WO2007104566A1 - Mittel zur behandlung von tinnitus - Google Patents

Mittel zur behandlung von tinnitus Download PDF

Info

Publication number
WO2007104566A1
WO2007104566A1 PCT/EP2007/002294 EP2007002294W WO2007104566A1 WO 2007104566 A1 WO2007104566 A1 WO 2007104566A1 EP 2007002294 W EP2007002294 W EP 2007002294W WO 2007104566 A1 WO2007104566 A1 WO 2007104566A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
use according
magnesium
tinnitus
blueberry extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/002294
Other languages
German (de)
English (en)
French (fr)
Inventor
Uwe Stoldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/282,691 priority Critical patent/US20090220592A1/en
Priority to JP2008558724A priority patent/JP2009529559A/ja
Priority to EA200801890A priority patent/EA013457B1/ru
Priority to EP07711962A priority patent/EP1993578A1/de
Priority to CA002646528A priority patent/CA2646528A1/en
Priority to AU2007224668A priority patent/AU2007224668A1/en
Publication of WO2007104566A1 publication Critical patent/WO2007104566A1/de
Priority to IL194066A priority patent/IL194066A0/en
Anticipated expiration legal-status Critical
Priority to US13/188,180 priority patent/US20110280972A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/EP2007/002294 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus Ceased WO2007104566A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US12/282,691 US20090220592A1 (en) 2006-03-15 2007-03-15 Preparation for the treatment of tinnitus
JP2008558724A JP2009529559A (ja) 2006-03-15 2007-03-15 耳鳴り治療用製剤
EA200801890A EA013457B1 (ru) 2006-03-15 2007-03-15 Средство для лечения шума в ушах
EP07711962A EP1993578A1 (de) 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus
CA002646528A CA2646528A1 (en) 2006-03-15 2007-03-15 Substance for the treatment of tinnitus
AU2007224668A AU2007224668A1 (en) 2006-03-15 2007-03-15 Substance for the treatment of tinnitus
IL194066A IL194066A0 (en) 2006-03-15 2008-09-14 Therapeutic composition for treatment of tinnitus
US13/188,180 US20110280972A1 (en) 2006-03-15 2011-07-21 Preparation for the treatment of tinnitus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006011922A DE102006011922A1 (de) 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus
DE102006011922.3 2006-03-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/188,180 Division US20110280972A1 (en) 2006-03-15 2011-07-21 Preparation for the treatment of tinnitus

Publications (1)

Publication Number Publication Date
WO2007104566A1 true WO2007104566A1 (de) 2007-09-20

Family

ID=38229816

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/002294 Ceased WO2007104566A1 (de) 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus

Country Status (9)

Country Link
US (2) US20090220592A1 (enExample)
EP (1) EP1993578A1 (enExample)
JP (1) JP2009529559A (enExample)
AU (1) AU2007224668A1 (enExample)
CA (1) CA2646528A1 (enExample)
DE (1) DE102006011922A1 (enExample)
EA (1) EA013457B1 (enExample)
IL (1) IL194066A0 (enExample)
WO (1) WO2007104566A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011522850A (ja) * 2008-06-12 2011-08-04 メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン 睡眠障害を処置するための１−アミノ−アルキルシクロヘキサン誘導体
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019240293A1 (en) * 2018-03-23 2020-10-15 Vanessa Research, Inc. Compositions and methods for treating diarrheal diseases
KR102175201B1 (ko) * 2019-09-06 2020-11-06 (주)아이엠디팜 빌베리 추출물을 유효성분으로 함유하는 감각신경성 난청 예방 또는 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005092330A1 (de) * 2004-03-24 2005-10-06 Aiones The Brainpower Company Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6524619B2 (en) * 2000-01-27 2003-02-25 Chronorx, Inc. Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus
JP2002308752A (ja) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd 皮膚外用剤
DE202004004618U1 (de) * 2004-03-24 2004-05-19 Aiones The Brainpower Company Blaubeerextrakt
JP2005306882A (ja) * 2005-06-08 2005-11-04 Alan Smith Richard 感情的不安定の治療のための医薬の製造に有用な組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005092330A1 (de) * 2004-03-24 2005-10-06 Aiones The Brainpower Company Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP1993578A1 *
SMITH P F ET AL: "Ginkgo biloba extracts for tinnitus: More hype than hope?", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, vol. 100, no. 1-2, 22 August 2005 (2005-08-22), pages 95 - 99, XP004996509, ISSN: 0378-8741 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011522850A (ja) * 2008-06-12 2011-08-04 メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン 睡眠障害を処置するための１−アミノ−アルキルシクロヘキサン誘導体
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Also Published As

Publication number Publication date
IL194066A0 (en) 2009-09-22
US20090220592A1 (en) 2009-09-03
EP1993578A1 (de) 2008-11-26
AU2007224668A1 (en) 2007-09-20
CA2646528A1 (en) 2007-09-20
EA013457B1 (ru) 2010-04-30
US20110280972A1 (en) 2011-11-17
EA200801890A1 (ru) 2009-04-28
JP2009529559A (ja) 2009-08-20
DE102006011922A1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
DE69804281T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Leberkrankheiten
DE60208216T2 (de) Verfahren zur behandlung von mittelohrinfektionen
WO1995017889A1 (en) Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
DE69821524T2 (de) Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln
WO2009036906A1 (de) Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation
WO2007104566A1 (de) Mittel zur behandlung von tinnitus
US20120009278A1 (en) Composition To Retard the Onset of Symptoms of Alzheimer's Disease
DE102020134587B4 (de) 1,8-Cineol enthaltende Zusammensetzung für die therapeutische Verwendung
Kocher Concerning pathological manifestations in low-grade thyroid diseases
EP2688577B1 (de) Zusammensetzung zur anwendung bei verdauungsbeschwerden
US20090274780A1 (en) Menopause treatment composition and regimen
EP4248955A2 (de) Verfahren zur herstellung von leicht einzunehmenden tabletten mit trockenextrakt aus ginkgo biloba blättern
CN109350660A (zh) 一种润肠通便的复方制剂及其制备方法
DE3116859A1 (de) Therapeutische zubereitungen fuer die behandlung einer tardiven dyskinesie
WO2005092330A1 (de) Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe
DE202004006157U1 (de) Arzneimittel bzw. Nahrungsergänzungsmittel
US11911431B2 (en) Sustained release ashwagandha extract
EP2355815B1 (de) Verwendung von leukotrien-inhibitoren zur behandlung von lungenerkrankungen bei frühgeborenen kindern
CN114617916A (zh) 一种枇杷叶提取物及其在康养方面中的应用
DE202014005450U1 (de) Lactosefreies Arzneimittel
DE102008033254B4 (de) Verfahren zur Herstellung eines einphasischen pharmazeutischen Präparates zur oralen Therapie der Regulierung des Blutdruckes
Wiesenauer et al. New approaches to treating pollenosis—a pilot study
DE2922478A1 (de) Arzneimittel zur behandlung von kreislauferkrankungen
CN103479821B (zh) 一种补肾益血的中药组合物及其制备方法
DE102011111944A1 (de) Verwendung von Diclofenac zur Verhinderung und Behandlung grippaler Infekte sowie durch grippale Infekte bewirkter Krankheitssymtome

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07711962

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2007711962

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007224668

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 194066

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2646528

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008558724

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 200801890

Country of ref document: EA

ENP Entry into the national phase

Ref document number: 2007224668

Country of ref document: AU

Date of ref document: 20070315

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12282691

Country of ref document: US